Jayex Technology Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Los beneficios de Jayex Technology han disminuido a una tasa media anual de -38.9%, mientras que en la industria Healthcare Services los beneficios crecieron en un 14.3% anualmente. Los ingresos han ido disminuyendo a una tasa media de 13.6% al año.

Información clave

-38.9%

Tasa de crecimiento de los beneficios

-30.1%

Tasa de crecimiento del BPA

Crecimiento de la industria Healthcare Services	42.6%
Tasa de crecimiento de los ingresos	-13.6%
Rentabilidad financiera	n/a
Margen neto	-105.5%
Última actualización de beneficios	31 Dec 2023

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos

Cómo gana y gasta dinero Jayex Technology. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

CHIA:JTL Ingresos, gastos y beneficios (AUD Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Dec 23	4	-4	2
30 Sep 23	4	-5	2
30 Jun 23	4	-6	2
31 Mar 23	4	-6	2
31 Dec 22	5	-6	2
30 Sep 22	5	-5	2
30 Jun 22	5	-3	2
31 Mar 22	5	-4	2
31 Dec 21	5	-4	2
30 Sep 21	4	-3	2
30 Jun 21	4	-3	1
31 Mar 21	5	-2	2
31 Dec 20	6	-1	2
30 Sep 20	6	-1	1
30 Jun 20	7	0	1
31 Mar 20	7	-1	1
31 Dec 19	7	-1	1
30 Sep 19	7	-1	1
30 Jun 19	7	-1	2
31 Mar 19	7	-1	2
31 Dec 18	7	-1	2
30 Sep 18	7	-1	2
30 Jun 18	7	-1	2
31 Mar 18	7	-2	2
31 Dec 17	8	-2	2
30 Sep 17	7	-4	2
30 Jun 17	7	-5	2
31 Mar 17	8	-5	2
31 Dec 16	9	-5	2
30 Jun 16	7	-4	2
31 Mar 16	4	-4	1
31 Dec 15	2	-3	1
30 Jun 15	1	-1	1
30 Jun 14	0	0	0

Ingresos de calidad: JTL actualmente no es rentable.

Margen de beneficios creciente: JTL actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: JTL no es rentable, y las pérdidas han aumentado en los últimos 5 años a un ritmo de 38.9% al año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de JTL en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: JTL no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Healthcare Services (14.3%).

Rentabilidad financiera

Alta ROE: El pasivo de JTL supera su activo, por lo que es difícil calcular su rentabilidad financiera.

Jayex Technology Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

First half 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2022)

Full year 2022 earnings released: AU$0.024 loss per share (vs AU$0.019 loss in FY 2021)

First half 2022 earnings released: AU$0.004 loss per share (vs AU$0.008 loss in 1H 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Recent updates

Jayex Technology Limited, Annual General Meeting, Jul 04, 2024

Less than half of directors are independent

Jayex Technology Limited Announces Directorate Changes

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

First half 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2022)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Full year 2022 earnings released: AU$0.024 loss per share (vs AU$0.019 loss in FY 2021)

Jayex Technology Limited Announces Resignation of Nathan Woodard as Chief Financial Officer, Effective January 31, 2023

No independent directors

No independent directors

Jayex Technology Limited Announces Resignation of Michael Chan as Non-Executive Director

No independent directors

No independent directors

Jayex Technology Limited Appoints Robert Hadle as Chief Executive Officer, Effective 3 October 2022

First half 2022 earnings released: AU$0.004 loss per share (vs AU$0.008 loss in 1H 2021)

No independent directors

No independent directors

No independent directors

Jayex Technology Limited, Annual General Meeting, May 26, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

No independent directors

Jayex Technology Limited has completed a Follow-on Equity Offering in the amount of AUD 0.572723 million.

Jayex Healthcare Limited announced that it expects to receive AUD 0.572723 million in funding

Vitalhub Corp. (TSXV:VHI) completed the acquisition of Assets of On-premises Acute (hospital) queue management business of Jayex Healthcare Limited (ASX:JHL).

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Jayex Healthcare Limited, Annual General Meeting, May 27, 2021

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Jayex Healthcare Limited announced that it expects to receive AUD 0.7 million in funding

First half earnings released

Jayex Healthcare Limited Announces Resignation of Nick Fernando as Group Chief Executive Officer Effective 25 July 2020

Desglose de ingresos y gastos

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado